CHARACTERISTICS OF FIRST-LINE UPADACITINIB INITIATORS AND FACTORS CONTRIBUTING TO PRESCRIBING UPADACITINIB AS FIRST-LINE B/ TSDMARD

被引:0
|
作者
Krueger, W. [1 ]
Harrold, L. [2 ]
Sima, A. [3 ]
Eckmann, T. [3 ]
Kilpatrick, R. [1 ]
机构
[1] AbbVie Inc, Chicago, IL USA
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
[3] CorEvitas, Waltham, MA USA
关键词
Disease-modifying Drugs (DMARDs); Real-world evidence; Rheumatoid arthritis;
D O I
10.1136/annrheumdis-2023-eular.3284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0445
引用
收藏
页码:1412 / 1412
页数:1
相关论文
共 50 条
  • [21] Which first-line antidepressant?
    Kendrick, Tony
    Taylor, David
    Johnson, Chris F.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2019, 69 (680): : 114 - 115
  • [22] First-Line Treatment for Hypertension
    Bui, Quynh
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (11) : 1333 - 1335
  • [23] First-line treatment for BPH
    不详
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 200 - 200
  • [24] FIRST-LINE ANTIBIOTICS FOR NEWBORN
    不详
    PATIENT CARE, 1974, 8 (13) : 149 - 149
  • [25] Lenacapavir in first-line therapy
    Orkin, Chloe
    LANCET HIV, 2023, 10 (01): : E2 - E3
  • [26] Are thiazolidinediones first-line agents?
    Weldy, DL
    JOURNAL OF FAMILY PRACTICE, 2002, 51 (11): : 984 - 984
  • [27] First-line management in children
    Olivier, C
    PRESSE MEDICALE, 1998, 27 : 7 - 8
  • [28] Lamivudine: is it first-line therapy?
    Dienstag, JL
    ANTIVIRAL THERAPY, 2002, 7 (04) : L83 - L83
  • [29] Audit on factors influencing the choice of first-line HAART
    Sanmani, L.
    Priestley, C.
    Schroeder, K.
    HIV MEDICINE, 2011, 12 : 85 - 85
  • [30] Impact of regional ARV prescribing guidance on choice of first-line therapy
    Marshall, N.
    Smith, C.
    Figueroa, J.
    Sharott, P.
    Peck, J.
    Curtis, H.
    Mackie, N.
    Clift, P.
    Wilcock, P.
    HIV MEDICINE, 2016, 17 : 11 - 12